> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Abbott Labeling Removes Aspirin from Heart Pump
- URL: https://www.fdaweb.com/abbott-labeling-removes-aspirin-from-heart-pump/
- Published: 2024-08-21T12:00:00.000Z
- Updated: 2026-09-14T14:39:11.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5157622

FDA has approved an Abbott PMA supplement to modify the labeling on its HeartMate 3 left ventricular assist device (LVAD, or heart pump) to eliminate aspirin as part of routine patient management. The company notes that blood thinners have routinely been used by patients receiving LVADs to reduce the risk of blood clots associated with the devices.

The labeling change is based on data from the ARIES-HM3 study that showed patients who received an Abbott HeartMate 3 heart pump but didn't take aspirin as part of their blood-thinning medication regimen had nearly 40% fewer complications from bleeding without increasing the risk of forming a blood clot compared to patients who also received a HeartMate 3 but did take aspirin, Abbott says. “As a result of reduced bleeding risk, the ARIES-HM3 trial also found patients avoiding aspirin post-implant experienced reduced days in the hospital compared to patients who took aspirin daily,” it adds.